Interferon-y is produced by another player of innate immune responses: The interferon-producing killer dendritic cell (IKDC)

被引:21
作者
Bonmort, Mathieu
Ullrich, Evelyn
Mignot, Gregoire
Jacobs, Benedikt
Chaput, Nathalie
Zitvogel, Laurence
机构
[1] Inst Gustave Roussy, U805, INSERM, F-94805 Villejuif, France
[2] Univ Paris 11, Fac Paris Sud, Kremelin Bicetre, France
[3] INSERM, CBT 507, Villejuif, France
基金
澳大利亚研究理事会;
关键词
interferon-gamma; TNF-related apoptosis-inducing ligand; interferon-producing killer dendritic cells; dendritic cells; tumor immunity; c-kit tyrosine kinase inhibitor; imatimb mesylate; interleukin-2;
D O I
10.1016/j.biochi.2007.04.014
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Interferon-gamma is a key cytokine in tumor immunosurveillance. The recently described interferon-producing killer dendritic cell (IKDC), can be distinguished from other innate effectors by its ability to kill a large variety of tumor cells and to produce high amounts of interferon-gamma after encountering tumors in the absence of exogenous cytokines. The cytotoxic activity of IKDC was unraveled during an efficient immunotherapy combining c-kit tyrosine kinase inhibitors and interleukin-2, and is mediated through tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and interferon type IIR. (C) 2007 Published by Elsevier Masson SAS.
引用
收藏
页码:872 / 877
页数:6
相关论文
共 32 条
[1]   Safety and antitumor activity of recombinant soluble Apo2 ligand [J].
Ashkenazi, A ;
Pai, RC ;
Fong, S ;
Leung, S ;
Lawrence, DA ;
Masters, SA ;
Blackie, C ;
Chang, L ;
McMurtrey, AE ;
Hebert, A ;
DeForge, L ;
Koumenis, IL ;
Lewis, D ;
Harris, L ;
Bussiere, J ;
Koeppen, H ;
Shahrokh, Z ;
Schwall, RH .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 104 (02) :155-162
[2]   Dendritic cells and the control of immunity [J].
Banchereau, J ;
Steinman, RM .
NATURE, 1998, 392 (6673) :245-252
[3]  
BOON T, 1994, ANNU REV IMMUNOL, V12, P337, DOI 10.1146/annurev.iy.12.040194.002005
[4]   Novel mode of action of c-kit tyrosine kinase inhibitors leading to NK cell-dependent antitumor effects [J].
Borg, C ;
Terme, M ;
Taïeb, J ;
Ménard, C ;
Flament, C ;
Robert, C ;
Maruyama, K ;
Wakasugi, H ;
Angevin, E ;
Thielemans, K ;
Le Cesne, A ;
Chung-Scott, V ;
Lazar, V ;
Tchou, I ;
Crépineau, F ;
Lemoine, F ;
Bernard, J ;
Fletcher, JA ;
Turhan, A ;
Blay, JY ;
Spatz, A ;
Emile, JF ;
Heinrich, MC ;
Mécheri, S ;
Tursz, T ;
Zitvogel, L .
JOURNAL OF CLINICAL INVESTIGATION, 2004, 114 (03) :379-388
[5]   Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death [J].
Casares, N ;
Pequignot, MO ;
Tesniere, A ;
Ghiringhelli, F ;
Roux, S ;
Chaput, N ;
Schmitt, E ;
Hamai, A ;
Hervas-Stubbs, S ;
Obeid, M ;
Coutant, F ;
Métivier, D ;
Pichard, E ;
Aucouturier, P ;
Pierron, G ;
Garrido, C ;
Zitvogel, L ;
Kroemer, G .
JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 202 (12) :1691-1701
[6]   Interferon-producing killer dendritic cells provide a link between innate and adaptive immunity [J].
Chan, CW ;
Crafton, E ;
Fan, HN ;
Flook, J ;
Yoshimura, K ;
Skarica, M ;
Brockstedt, D ;
Dubensky, TW ;
Stins, MF ;
Lanier, LL ;
Pardoll, DM ;
Housseau, F .
NATURE MEDICINE, 2006, 12 (02) :207-213
[7]   Increased susceptibility to tumor initiation and metastasis in TNF-related apoptosis-inducing ligand-deficient mice [J].
Cretney, E ;
Takeda, K ;
Yagita, H ;
Glaccum, M ;
Peschon, JJ ;
Smyth, MJ .
JOURNAL OF IMMUNOLOGY, 2002, 168 (03) :1356-1361
[8]   Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity [J].
Diefenbach, A ;
Jensen, ER ;
Jamieson, AM ;
Raulet, DH .
NATURE, 2001, 413 (6852) :165-171
[9]   Interferons, immunity and cancer immunoediting [J].
Dunn, Gavin P. ;
Koebel, Catherine M. ;
Schreiber, Robert D. .
NATURE REVIEWS IMMUNOLOGY, 2006, 6 (11) :836-848
[10]   Human dendritic cells mediate cellular apoptosis via tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) [J].
Fanger, NA ;
Maliszewski, CR ;
Schooley, K ;
Griffith, TS .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 190 (08) :1155-1164